TR201914034A2 - Schi̇sandri̇n b etken maddesi̇ni̇n multi̇ple sklerozi̇s hastaliğinda i̇laç adayi olarak kullanilmasi - Google Patents
Schi̇sandri̇n b etken maddesi̇ni̇n multi̇ple sklerozi̇s hastaliğinda i̇laç adayi olarak kullanilmasiInfo
- Publication number
- TR201914034A2 TR201914034A2 TR2019/14034A TR201914034A TR201914034A2 TR 201914034 A2 TR201914034 A2 TR 201914034A2 TR 2019/14034 A TR2019/14034 A TR 2019/14034A TR 201914034 A TR201914034 A TR 201914034A TR 201914034 A2 TR201914034 A2 TR 201914034A2
- Authority
- TR
- Turkey
- Prior art keywords
- schisandrin
- multiple sclerosis
- usage
- drug candidate
- sclerosis disease
- Prior art date
Links
- 201000006417 multiple sclerosis Diseases 0.000 title abstract 3
- 229940000406 drug candidate Drugs 0.000 title abstract 2
- RTZKSTLPRTWFEV-OLZOCXBDSA-N Deoxygomisin A Chemical compound COC1=C2C=3C(OC)=C(OC)C(OC)=CC=3C[C@@H](C)[C@@H](C)CC2=CC2=C1OCO2 RTZKSTLPRTWFEV-OLZOCXBDSA-N 0.000 title 1
- RTZKSTLPRTWFEV-UHFFFAOYSA-N Isokadsuranin Natural products COC1=C2C=3C(OC)=C(OC)C(OC)=CC=3CC(C)C(C)CC2=CC2=C1OCO2 RTZKSTLPRTWFEV-UHFFFAOYSA-N 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- RTZKSTLPRTWFEV-QWHCGFSZSA-N Gomisin L1 methyl ether Chemical compound COC1=C2C=3C(OC)=C(OC)C(OC)=CC=3C[C@H](C)[C@H](C)CC2=CC2=C1OCO2 RTZKSTLPRTWFEV-QWHCGFSZSA-N 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 235000015872 dietary supplement Nutrition 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Buluş, Schisandrin B (Sch-B) etken maddesinin Multiple Sklerozis (MS) hastalığı tedavisinde ilaç adayı veya gıda takviyesi olarak kullanımı ile ilgilidir.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TR2019/14034A TR201914034A2 (tr) | 2019-09-16 | 2019-09-16 | Schi̇sandri̇n b etken maddesi̇ni̇n multi̇ple sklerozi̇s hastaliğinda i̇laç adayi olarak kullanilmasi |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TR2019/14034A TR201914034A2 (tr) | 2019-09-16 | 2019-09-16 | Schi̇sandri̇n b etken maddesi̇ni̇n multi̇ple sklerozi̇s hastaliğinda i̇laç adayi olarak kullanilmasi |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TR201914034A2 true TR201914034A2 (tr) | 2021-04-21 |
Family
ID=76502943
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TR2019/14034A TR201914034A2 (tr) | 2019-09-16 | 2019-09-16 | Schi̇sandri̇n b etken maddesi̇ni̇n multi̇ple sklerozi̇s hastaliğinda i̇laç adayi olarak kullanilmasi |
Country Status (1)
| Country | Link |
|---|---|
| TR (1) | TR201914034A2 (tr) |
-
2019
- 2019-09-16 TR TR2019/14034A patent/TR201914034A2/tr unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JOP20220008A1 (ar) | مثبطات parp1 | |
| JOP20200011B1 (ar) | مركبات وتركيبات لمعالجة حالات مرضية مرتبطة بنشاط nlrp | |
| PH12020551205A1 (en) | Fap inhibitors | |
| CO2021012579A2 (es) | Compuestos útiles en la terapia del vih | |
| JOP20170107B1 (ar) | مشتقات سلفوناميد عطرية | |
| BR112013028666A2 (pt) | compostos de pirazolo sulfonamida tricícilos e métodos para fazer e usar o mesmo | |
| UA89220C2 (ru) | Способ лечения вич/спида путем приема без пищи или в условиях голодания твердого фармацевтического дозированного состава ингибитора вич-протеазы | |
| BR112014017673A8 (pt) | Compostos de sulfonamida tricíclicos e métodos para fazer e usar os mesmos | |
| EA201390662A1 (ru) | Фармацевтическая композиция, содержащая дутастерид | |
| ZA202006377B (en) | Boronic acid derivatives and therapeutic uses thereof | |
| MX2020011100A (es) | Compuestos, composiciones farmaceuticas y metodos de uso de agonistas de ppar. | |
| BR112014017780A8 (pt) | Compostos de sulfona tricíclicos e métodos para fazer e usar os mesmos | |
| EA201792591A1 (ru) | Фармацевтические препараты | |
| CL2021001388A1 (es) | Compuestos útiles en la terapia para el vih | |
| EA201890532A1 (ru) | Новые аннелированные бензамиды | |
| GEP20237486B (en) | Formulations of copanlisib | |
| MX2020011756A (es) | Compuesto farmaceutico, sales del mismo, formulaciones del mismo y metodos para hacer y usar el mismo. | |
| EA201992117A1 (ru) | Фармацевтическая комбинация, содержащая понесимод | |
| EA201992389A1 (ru) | Замещенные n-арилэтил-2-аминохинолин-4-карбоксамиды и их применение | |
| TR201914043A1 (tr) | Dapagli̇flozi̇n ve metformi̇n i̇çeren efervesan tablet formülasyonlari | |
| ZA201906153B (en) | Pharmaceutical compositions for combination therapy | |
| ECSP22058286A (es) | Agente profiláctico y/o terapéutico para la prostatitis crónica/síndrome de dolor pélvico crónico | |
| EA201890929A1 (ru) | Низкие дозировки композиций дипиридамола для перорального приема и их использование | |
| CL2020000251A1 (es) | Derivado de adamantilmetilamina y uso del mismo como producto farmacéutico. | |
| TR201914037A2 (tr) | Alantolacton etken maddesi̇ni̇n multi̇ple sklerozi̇s hastaliğinda i̇laç adayi olarak kullanilmasi |